Learn how frameworks like Solid, Svelte, and Angular are using the Signals pattern to deliver reactive state without the ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.

Getting back into running after a long break is a slog. Those first few workouts will make you wonder if you ever really enjoyed running in the first place. You can’t catch your breath. You’d swear ...

Runners often want to know how they compare to their peers when it comes to race times, workouts, and of course, mileage. That’s not to say you should try to match Fasty McFast who has been running ...

Jason Chun is a CNET writer covering a range of topics in tech, home, wellness, finance and streaming services. He is passionate about language and technology, and has been an avid writer/reader of ...

ZDNET experts put every product through rigorous testing and research to curate the best options for you. If you buy through our links, we may earn a commission. Learn Our Process 'ZDNET Recommends': ...

More than one year since massive foreign aid cuts and the eventual closure of the U.S. Agency for International Development, Oxfam outlines what USAID did and the ripple effects of losing it. U.S.